What is the best medication for managing hypertension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Best Medications for Hypertension Management

For most patients with hypertension, a combination therapy approach using a renin-angiotensin system (RAS) blocker (ACE inhibitor or ARB) with either a calcium channel blocker (CCB) or a thiazide/thiazide-like diuretic is recommended as the most effective first-line treatment. 1

First-Line Medication Options

  • ACE inhibitors (e.g., lisinopril), ARBs (e.g., losartan), dihydropyridine CCBs, and thiazide/thiazide-like diuretics have demonstrated the most effective reduction of blood pressure and cardiovascular events 1
  • Single-pill combinations of these medications improve adherence and should be preferred when combination therapy is used 1
  • For most patients with confirmed hypertension (BP ≥140/90 mmHg), initial therapy should be a two-drug combination rather than monotherapy 1

Recommended Treatment Algorithm

  1. Initial Treatment:

    • For most patients with hypertension: Start with a two-drug combination of a RAS blocker (ACE inhibitor or ARB) plus either a CCB or thiazide/thiazide-like diuretic 1
    • Preferably use a single-pill combination to improve adherence 1
  2. If BP not controlled after 1-3 months:

    • Increase to a three-drug combination: RAS blocker + CCB + thiazide/thiazide-like diuretic 1
    • Again, preferably as a single-pill combination 1
  3. If BP still not controlled (resistant hypertension):

    • Add spironolactone as fourth-line agent 1
    • If spironolactone is not tolerated, consider eplerenone, beta-blockers, or other agents 1

Special Considerations

  • Beta-blockers are not recommended as first-line treatment unless there are specific indications such as angina, post-myocardial infarction, heart failure, or for heart rate control 1
  • Combining two RAS blockers (ACE inhibitor and ARB) is not recommended due to increased adverse effects without additional benefit 1
  • In Black patients, a CCB combined with either a thiazide diuretic or a RAS blocker should be considered 1
  • In elderly patients (≥65 years), treatment should be initiated more gradually, with careful monitoring for orthostatic hypotension 1

Blood Pressure Targets

  • For most adults: Target BP of 120-129/70-79 mmHg, provided treatment is well tolerated 1
  • If achieving this target is not possible or treatment is not well tolerated, aim for "as low as reasonably achievable" 1
  • For older patients (≥65 years): Target systolic BP of 130-139 mmHg 1
  • For patients aged ≥85 years or with frailty: Consider more lenient targets (e.g., <140/90 mmHg) 1

Medication Efficacy and Benefits

  • ACE inhibitors like lisinopril provide effective BP reduction without affecting heart rate or cardiovascular reflexes 2, 3
  • ARBs like losartan are effective in lowering BP and have additional benefits in patients with left ventricular hypertrophy or diabetic nephropathy 4
  • A 10 mmHg reduction in systolic BP decreases the risk of cardiovascular events by approximately 20-30% 5
  • Combination therapy allows for lower doses of individual medications, potentially reducing side effects while maintaining efficacy 1

Common Pitfalls to Avoid

  • Delaying intensification of therapy when BP targets are not met 1
  • Using monotherapy in patients with moderate-to-severe hypertension, which is often insufficient 1
  • Failing to consider medication adherence when BP is not controlled 1
  • Using over-the-counter cold medications containing sympathomimetics (e.g., pseudoephedrine), which can significantly increase BP 6
  • Combining NSAIDs with antihypertensive medications, as NSAIDs can antagonize the effects of RAS inhibitors and beta-blockers 6

By following this evidence-based approach to hypertension management, clinicians can effectively reduce blood pressure and minimize the risk of cardiovascular events, stroke, and mortality in their patients.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Lisinopril in the treatment of hypertension.

Journal of human hypertension, 1989

Guideline

Cold Medicine Recommendations for Patients with Hypertension

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.